|Articles|May 10, 2011

Is It Child Abuse?

Title for child abuse portlet CFP

Is It Child Abuse?

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!

Related Content

High-dose therapy boosts arm function in infants after perinatal stroke

ByMorgan Ebert, Managing Editor

February 6th 2026

Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children

ByRenuka Dias, PhD, MBBS

February 6th 2026

FDA grants priority review to marstacimab for younger children and patients with hemophilia inhibitors

FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors

ByMorgan Ebert, Managing Editor

February 6th 2026

Parental concerns about disordered eating common in overweight children

ByCeleste Krewson, Assistant Editor

February 6th 2026

Infant botulism outbreak linked to powdered formula under FDA investigation

ByMorgan Ebert, Managing Editor

February 5th 2026

Latest CME

Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Is It Child Abuse?

Is It Child Abuse?

Newsletter

Related Content

High-dose therapy boosts arm function in infants after perinatal stroke

Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children

FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors

Parental concerns about disordered eating common in overweight children

Infant botulism outbreak linked to powdered formula under FDA investigation

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Trending on Contemporary Pediatrics

Steroid Safety, Growth Concerns, and When to Escalate Pediatric Therapy

Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children

FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors

Infant botulism outbreak linked to powdered formula under FDA investigation

AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older